Literature DB >> 32930521

MAFLD vs NAFLD: Let the contest begin!

Cristiana Bianco1, Stefano Romeo2,3, Salvatore Petta4, Michelle T Long5, Luca Valenti1,6.   

Abstract

Entities:  

Keywords:  fatty liver disease; insulin resistance; metabolism; obesity; steatosis

Mesh：

Year:  2020        PMID： 32930521      PMCID： PMC7510483          DOI： 10.1111/liv.14620

Source DB:  PubMed          Journal:  Liver Int        ISSN： 1478-3223            Impact factor:   8.754


× No keyword cloud information.
  12 in total

1.  Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030.

Authors:  Chris Estes; Quentin M Anstee; Maria Teresa Arias-Loste; Heike Bantel; Stefano Bellentani; Joan Caballeria; Massimo Colombo; Antonio Craxi; Javier Crespo; Christopher P Day; Yuichiro Eguchi; Andreas Geier; Loreta A Kondili; Daniela C Kroy; Jeffrey V Lazarus; Rohit Loomba; Michael P Manns; Giulio Marchesini; Atsushi Nakajima; Francesco Negro; Salvatore Petta; Vlad Ratziu; Manuel Romero-Gomez; Arun Sanyal; Jörn M Schattenberg; Frank Tacke; Junko Tanaka; Christian Trautwein; Lai Wei; Stefan Zeuzem; Homie Razavi
Journal:  J Hepatol       Date:  2018-06-08       Impact factor: 25.083

Review 2.  A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.

Authors:  Mohammed Eslam; Philip N Newsome; Shiv K Sarin; Quentin M Anstee; Giovanni Targher; Manuel Romero-Gomez; Shira Zelber-Sagi; Vincent Wai-Sun Wong; Jean-François Dufour; Jörn M Schattenberg; Takumi Kawaguchi; Marco Arrese; Luca Valenti; Gamal Shiha; Claudio Tiribelli; Hannele Yki-Järvinen; Jian-Gao Fan; Henning Grønbæk; Yusuf Yilmaz; Helena Cortez-Pinto; Claudia P Oliveira; Pierre Bedossa; Leon A Adams; Ming-Hua Zheng; Yasser Fouad; Wah-Kheong Chan; Nahum Mendez-Sanchez; Sang Hoon Ahn; Laurent Castera; Elisabetta Bugianesi; Vlad Ratziu; Jacob George
Journal:  J Hepatol       Date:  2020-04-08       Impact factor: 25.083

3.  Redefining fatty liver disease classification in 2020.

Authors:  Luca Valenti; Serena Pelusi
Journal:  Liver Int       Date:  2020-05       Impact factor: 5.828

4.  Comparison of MAFLD and NAFLD diagnostic criteria in real world.

Authors:  Su Lin; Jiaofeng Huang; Mingfang Wang; Rahul Kumar; Yuxiu Liu; Shiying Liu; Yinlian Wu; Xiaozhong Wang; Yueyong Zhu
Journal:  Liver Int       Date:  2020-07-26       Impact factor: 5.828

Review 5.  What's in a name? Renaming 'NAFLD' to 'MAFLD'.

Authors:  Yasser Fouad; Imam Waked; Steven Bollipo; Ahmed Gomaa; Yousef Ajlouni; Dina Attia
Journal:  Liver Int       Date:  2020-04-28       Impact factor: 5.828

Review 6.  Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference.

Authors:  Brent A Neuschwander-Tetri; Stephen H Caldwell
Journal:  Hepatology       Date:  2003-05       Impact factor: 17.425

Review 7.  Update on NAFLD genetics: From new variants to the clinic.

Authors:  Eric Trépo; Luca Valenti
Journal:  J Hepatol       Date:  2020-03-04       Impact factor: 25.083

8.  The amount of liver fat predicts mortality and development of type 2 diabetes in non-alcoholic fatty liver disease.

Authors:  Patrik Nasr; Mats Fredrikson; Mattias Ekstedt; Stergios Kechagias
Journal:  Liver Int       Date:  2020-03-10       Impact factor: 5.828

9.  Alcohol Use Is Associated With Hepatic Steatosis Among Persons With Presumed Nonalcoholic Fatty Liver Disease.

Authors:  Michelle T Long; Joseph M Massaro; Udo Hoffmann; Emelia J Benjamin; Timothy S Naimi
Journal:  Clin Gastroenterol Hepatol       Date:  2019-11-14       Impact factor: 11.382

Review 10.  Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet       Date:  2018-08-23       Impact factor: 202.731
View more
  5 in total

Review 1.  MAFLD and CKD: An Updated Narrative Review.

Authors:  Alessandro Mantovani; Rosa Lombardi; Filippo Cattazzo; Chiara Zusi; Davide Cappelli; Andrea Dalbeni
Journal:  Int J Mol Sci       Date:  2022-06-23       Impact factor: 6.208

Review 2.  Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management.

Authors:  Amedeo Lonardo; Juan Pablo Arab; Marco Arrese
Journal:  Adv Ther       Date:  2021-04-07       Impact factor: 3.845

3.  Bergamot Polyphenol Extract Reduces Hepatocyte Neutral Fat by Increasing Beta-Oxidation.

Authors:  Angela Mirarchi; Rosario Mare; Vincenzo Musolino; Saverio Nucera; Vincenzo Mollace; Arturo Pujia; Tiziana Montalcini; Stefano Romeo; Samantha Maurotti
Journal:  Nutrients       Date:  2022-08-20       Impact factor: 6.706

Review 4.  Insight into Potential Interactions of Thyroid Hormones, Sex Hormones and Their Stimulating Hormones in the Development of Non-Alcoholic Fatty Liver Disease.

Authors:  Eleonore Fröhlich; Richard Wahl
Journal:  Metabolites       Date:  2022-08-04

5.  A minority of somatically mutated genes in pre-existing fatty liver disease have prognostic importance in the development of NAFLD.

Authors:  Jake P Mann; Matthew Hoare
Journal:  Liver Int       Date:  2022-05-11       Impact factor: 8.754
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.